Related Experiment Video
Updated: Oct 18, 2025
09:28
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
Published on: November 17, 2018
11.8K
Magnetically sensitive nanocomplex enhances antitumor efficacy of dendritic cell-based immunotherapy
N Khranovska1, O Skachkova1, O Gorbach1
1National Cancer Institute of Ukraine, Kyiv 03022, Ukraine.
Experimental Oncology
|September 30, 2021
Summary
Magnetically sensitive dendritic cell (DC) nanovaccines enhance antitumor effects by improving DC migration to lymph nodes. This approach significantly reduces tumor growth and modulates the tumor microenvironment, offering a promising strategy for cancer immunotherapy.
Area of Science:
- Immunology
- Biotechnology
- Nanomedicine
Background:
- Inefficient migration of dendritic cells (DCs) to lymphoid tissues limits the in vivo efficacy of DC-based immunotherapy.
- Magnetically sensitive nanocomplexes offer a novel approach to enhance DC delivery to lymph nodes, potentially improving antitumor effects.
Purpose of the Study:
- To investigate the antitumor and immunomodulatory effects of a magnetosensitive DC nanovaccine.
- To assess the nanovaccine's impact on the immunosuppressive tumor microenvironment in a mouse model of sarcoma 37.
Main Methods:
- Investigated the effects of DCs loaded with magnetic nanocomplexes under magnetic field (MF) control in mice with sarcoma 37.
- Evaluated antitumor, antimetastatic, and immunomodulatory effects.
Main Results:
- Combined therapy significantly reduced tumor volume and weight compared to control groups.
- Magnetosensitive DC nanovaccine with MF control downregulated immunosuppressive factors (FoxP3, TGF-β, IL-10, VEGF) mRNA expression.
- Increased expression of pro-inflammatory cytokines (IFN-γ, IL-4) mRNA was observed.
Conclusions:
- Magnetosensitive nanocarriers of tumor antigens, guided by MF, significantly enhance the antitumor efficacy of DC vaccines.
- This targeted delivery system shows promise for improving cancer immunotherapy outcomes.
